I assume that will be up to the new CRO. Speaking of which, now that we've submitted the protocol for the P3 Registrational Trial, I wonder who that will be.
Quote:
NP should be recruiting hospitals in Michigan to be part of the new CD12 trials.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.